Should he continue active surveillance?
He is going for a biopsy and most likely radiation
Have his prostate removed or radiation?
Any helpful advice appreciated
EXAMINATION: MRI prostate without contrast
IMPRESSION:
Lesion #1: Apex left posterior peripheral zone, 1.7 cm, slightly increased since/the prior study. PI-RADS category 3 (the presence of clinically significant cancer is equivocal)
Lesion #2: Previously identified lesion not well-visualized on this exam.
Lesion #3: Base left posterolateral/posterior medial peripheral zone extending into the right posterior medial peripheral zone, not significantly changed the prior study. 2.5 cm transverse. PI-RADS category 3 (the presence of clinically significant cancer is equivocal)
No new lesions concerning for clinically significant prostate cancer.
CLINICAL INDICATION: prostate cancer :: C61 Malignant neoplasm of prostate
TECHNIQUE: MRI of the prostate was performed. The following sequences were obtained: T1 weighted without fat suppression in the axial plane with full field of view and coned-down field of view, T2 weighted without fat suppression in the axial, coronal, and sagittal planes with coned-down field of view and axial T1 with fat suppression with large field of view. Diffusion-weighted images were obtained as well. Images were reviewed on DynaCad.
COMPARISON: 9/21/2022
INTERPRETATION:
PROSTATE: The prostate measures 5.3 cm in craniocaudal by 4.2-cm in AP by 4.5-cm in transverse dimensions.
BACKGROUND PARENCHYMA:
* CENTRAL GLAND: BPH
* PERIPHERAL ZONE: Multiple linear/wedge-shaped T2/ADC hypointensities (PI-RADS 2).
DISCRETE LESIONS:
Lesion #1
Location: Apex left posterior peripheral zone
Size: 1.7 cm (506:136), previously 1.4 cm when measured in a similar fashion
T2 Score: 3 (Heterogeneous signal intensity, 401:12)
DWI/ADC Score: 3 (Focal hypointense on ADC and focal hyperintense on high b-value DWI; 506:136, 505:144)
Overall Assessment: PI-RADS category 3 (the presence of clinically significant cancer is equivocal)
Extraprostatic Extension: Absent
Lesion #2
Previous identified lesion 2 not well-visualized on this exam.
Lesion #3
Location: Base left posterolateral/posterior medial peripheral zone extending into the right posterior medial peripheral zone, not significantly changed the prior study
Size: 2.5 cm transverse (506:208) previously 2.5 cm when measured in a similar fashion
T2 Score: 3 (Heterogeneous signal intensity, 401:18)
DWI/ADC Score: 3 (Focal hypointense on ADC and focal hyperintense on high b-value DWI; 506:208, 505:192)
Overall Assessment: PI-RADS category 3 (the presence of clinically significant cancer is equivocal)
Extraprostatic Extension: Absent
NEUROVASCULAR BUNDLES: Intact bilaterally.
SEMINAL VESICLES: Atrophic, unchanged.
URINARY BLADDER: Underdistended, limiting evaluation.
LYMPH NODES: No pelvic lymphadenopathy.
OTHER: There is a lobulated cystic structure below the prostate and posterior to the left lateral aspect of the corpus spongiosum measuring 1.6 x 1.3 cm (4 1:5), new from the prior study. This is most consistent with a Cowper's duct syringocele.